We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$56.9B
AUM Growth
+$2.14B
Cap. Flow
-$875M
Cap. Flow %
-1.54%
Top 10 Hldgs %
31.9%
Holding
1,730
New
18
Increased
385
Reduced
488
Closed
24

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$98.8M
2
EL icon
Estee Lauder
EL
+$92.2M
3
NVDA icon
NVIDIA
NVDA
+$83M
4
AMAT icon
Applied Materials
AMAT
+$63.2M
5
AVGO icon
Broadcom
AVGO
+$58.1M

Sector Composition

Rank Sector Weight
1 Technology 30.11%
2 Healthcare 14.35%
3 Financials 12.69%
4 Consumer Discretionary 9.69%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VREX icon
1676
Varex Imaging
VREX
$463M
$285K ﹤0.01%
23,918
EMBC icon
1677
Embecta
EMBC
$204M
$284K ﹤0.01%
20,115
LWLG icon
1678
Lightwave Logic
LWLG
$945M
$278K ﹤0.01%
100,552
+3,400
+3% +$10.2K
BYND icon
1679
Beyond Meat
BYND
$283M
$275K ﹤0.01%
40,493
+4,000
+11% +$25.3K
OSG
1680
Octave Specialty Group
OSG
$258M
$271K ﹤0.01%
24,133
ATHM icon
1681
Autohome
ATHM
$2.46B
$253K ﹤0.01%
7,750
USNA icon
1682
Usana Health Sciences
USNA
$412M
$244K ﹤0.01%
6,445
SLNO
1683
DELISTED
Soleno Therapeutics
SLNO
$237K ﹤0.01%
4,701
VOR icon
1684
Vor Biopharma
VOR
$1.05B
$231K ﹤0.01%
16,469
-835
-5% -$15.2K
MXCT icon
1685
MaxCyte
MXCT
$109M
$230K ﹤0.01%
59,013
OLMA icon
1686
Olema Pharmaceuticals
OLMA
$1.05B
$225K ﹤0.01%
18,849
+4,000
+27% +$51.1K
OSUR icon
1687
OraSure Technologies
OSUR
$273M
$224K ﹤0.01%
52,519
INAB icon
1688
IN8bio
INAB
$11.4M
$224K ﹤0.01%
27,639
-9,637
-26% -$175K
IBRX icon
1689
ImmunityBio
IBRX
$7.32B
$222K ﹤0.01%
59,650
RBCAA icon
1690
Republic Bancorp
RBCAA
$1.9B
$221K ﹤0.01%
3,389
TNGX icon
1691
Tango Therapeutics
TNGX
$4.35B
$220K ﹤0.01%
28,619
-243,203
-89% -$2.32M
NFE icon
1692
New Fortress Energy
NFE
$96.4M
$200K ﹤0.01%
22,010
HTZ icon
1693
Hertz
HTZ
$632M
$174K ﹤0.01%
52,751
CABA icon
1694
Cabaletta Bio
CABA
$444M
$174K ﹤0.01%
36,873
+17,500
+90% +$101K
KVYO icon
1695
Klaviyo
KVYO
$5.31B
$173K ﹤0.01%
4,880
NUS icon
1696
Nu Skin
NUS
$250M
$147K ﹤0.01%
19,976
LINE
1697
Lineage Inc
LINE
$9.69B
$143K ﹤0.01%
+1,819
New +$152K
TTEC icon
1698
TTEC Holdings
TTEC
$107M
$134K ﹤0.01%
22,808
IQ icon
1699
iQIYI
IQ
$1.19B
$126K ﹤0.01%
44,150
GRAL
1700
GRAIL Inc
GRAL
$2.87B
$120K ﹤0.01%
8,727
-1,233
-12% -$18.7K

Similar funds

Ensign Peak Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Ensign Peak Advisors held 1,730 positions worth $56.9B, up 3.9% from $54.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 2.4%. Ensign Peak Advisors opened 18 new positions and exited 24, leaving the 1,730-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q3 2024 buy was Invesco QQQ Trust: 68,400 shares worth $33.4M.
  • Ensign Peak Advisors added most to Oracle in Q3 2024, an estimated $98.8M increase.
  • Ensign Peak Advisors's biggest Q3 2024 reduction was Microsoft, cutting an estimated $122M.
  • Ensign Peak Advisors fully exited Coupang in Q3 2024, selling an estimated $16.3M.
  • Ensign Peak Advisors's ten largest holdings make up 32% of its $56.9B portfolio in Q3 2024.
  • Ensign Peak Advisors opened 18 new positions and closed 24 in Q3 2024.
  • Ensign Peak Advisors's portfolio value rose 3.9% quarter-over-quarter to $56.9B.

Based on Ensign Peak Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.